Pharmaceutical Barium
Rare Earth Sourcing in the Land of the Blind
“America’s rare earth strategy is being led by the blind—misinterpreting unintended bureaucratic miscalculations in China as strategic manipulation.…
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
-
Voyageur Pharmaceuticals’ Brent Willis on the Indispensable Role of Barium
January 27, 2025 — In an enlightening interview on Investor.News, Brent Willis, President, CEO, and Director of Voyageur Pharmaceuticals…
No CommentsInvestorNews
-
Brent Willis on Voyageur Pharmaceuticals’ Shift to Innovative Barium Contrast Formulations and an FDA Update
September 17, 2024 — In a recent interview with InvestorNews host Tracy Hughes, Brent Willis, President, CEO, and Director…
No CommentsInvestorNews
-
Voyageur Pharmaceutical’s Brent Willis on Revolutionizing the Medical Imaging Industry, plus SmoothX
In a revealing interview on Investor.Coffee, host Tracy Weslosky engages in an enlightening conversation with Brent Willis, President,…
No CommentsInvestorNews
-
Voyageur Prepares to Launch SmoothX™ Barium Sulfate CT Contrast Media
The contrast media market is a large global market valued at $4.7 billion and is forecasted to grow…
No CommentsInvestorNews
-
Voyageur Pharmaceuticals completes FDA submission milestone for first barium contrast product license application
Radiographic contrast media are substances used in diagnostic imaging tests such as ultrasound, X-rays, CT scans and MRI…
No CommentsInvestorNews
-
Brent Willis of Voyageur Pharmaceuticals discusses the high IRR and NPV in its recent PEA
In a recent InvestorIntel interview, Tracy Weslosky spoke with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd. (TSXV:…
3 CommentsInvestorNews
Top 10 Trending
-
World Metal & Mining ETFs – Q1 2025 in Review
-
Technology Metals Report (04.11.2025): U.S.-China Trade War Escalates as Nations Accelerate Critical Mineral Strategies and Energy Supply Chain Realignments
-
Mid Atlantic Capital’s Charlie Flynn Unveils Proven Blueprint for Uncovering Undervalued Market Gems
IN8 Member News
-
American Rare Earths Channel Sampling Program Highlights TREO Grades up to 13,651 ppm
-
Ciscom Reports Steady Q1 2025 Earnings Amid Market Challenges
-
Energy Fuels Announces Q1-2025 Results
-
Nord Precious Metals Preliminary 3D model Shows Exploration Upside of Little-Explored Lower Contact of the “Productive Nipissing Diabase”
-
Romios Gold Resources Inc. Announces Termination of Letter of Intent With Star Gold Resources Corp.
